VPA Expanded UCB Transplantation for Treatment of Patients With Hematological Malignancies

NCT03885947 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Hematological Malignancy
Acute Leukemia in Remission
Acute Lymphoblastic Leukemia in Remission
Myelodysplastic Syndromes
Non-Hodgkin Lymphoma
Hodgkin Lymphoma

Interventions

BIOLOGICAL: Cord blood stem cells
DRUG: Valproic Acid
DRUG: Fludarabine
DRUG: cytoxan
DRUG: Thiotepa
BIOLOGICAL: TBI

Sponsor

Alla Keyzner